SIDE-BY-SIDE COMPARISON

CompareCleerlyvsUltromics

Review features, pricing signals, strengths, and trade-offs before choosing.

Generated from current catalog profiles Catalog profile signals Use-case comparison
AI Cardiology & Heart Imaging Software

Cleerly

SF 8.2

Coronary plaque analytics from CT angiography

Contact sales

Quick decision guide

Choose based on your workflow

Not enough differentiated product data yet to make a strong automatic pick.

Overview

How each tool is described

Cleerly

Cleerly is an AI-driven coronary artery disease imaging platform for cardiology programs, analyzing coronary CT angiography to characterize plaque, stenosis, and atherosclerosis risk.

  1. Clinical role: It supports cardiac imaging and risk stratification rather than autonomous cardiology, with cardiologist review remaining essential for every interpretation and related treatment decision.
  2. Best-fit environment: Programs with strong coronary CT volumes may benefit most from its focus on plaque characterization and cardiovascular risk assessment.
  3. Implementation checks: Buyers should assess regulatory clearance scope, imaging fit, reporting integration, clinical validation evidence, and workflow readiness before broader deployment.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, so teams should confirm service scope and support requirements.

A focused pilot can establish clinical workflow fit and implementation needs before a wider rollout.



View full Cleerly profile

Ultromics

Ultromics is an AI echocardiography platform for cardiology services, analyzing cardiac ultrasound images to support heart failure assessment, imaging review, and risk stratification.

  1. Clinical role: It supports cardiac imaging interpretation rather than autonomous cardiology, so cardiologists remain responsible for reviewing every output and making treatment or reporting decisions.
  2. Best-fit environment: Echocardiography labs with established imaging pathways may benefit most when implementing disease-focused analysis across active cardiology services.
  3. Evaluation priorities: Buyers should assess regulatory clearance, modality compatibility, reporting integration, clinical validation evidence, and adoption requirements before broader deployment.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, while availability and implementation depth vary by region.

Ultromics is best evaluated as a specialist echocardiography layer whose value depends on clinical oversight, workflow integration, and local clearance.

View full Ultromics profile

Side-by-side

Key differences

Criteria
AI Cardiology & Heart Imaging SoftwareCleerly
AI Cardiology & Heart Imaging SoftwareUltromics
Best for
AI Cardiology & Heart Imaging Software
AI Cardiology & Heart Imaging Software
Score
8.2/10
8.0/10
Pricing
Contact sales
Contact sales
Category / audience
AI Healthcare & Medical Software › AI Cardiology & Heart Imaging Software
AI Healthcare & Medical Software › AI Cardiology & Heart Imaging Software

OVERLAP

Where Cleerly and Ultromics are similar

Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.

4 capabilities5 workflows

Shared capabilities

Capability overlap

  • Image AnalysisAI analysis of cardiac imaging studies
  • Risk StratificationStratifies cardiovascular risk from inputs
  • Echo AnalysisAnalyzes echocardiogram images and clips
  • Workflow IntegrationConnects into cardiology reading workflow

Shared workflows

Workflow overlap

  • Support coronary artery disease evaluationSupport coronary artery disease evaluation from CT inputs.
  • Quantify plaque burden from coronary CTQuantify plaque burden and composition from coronary CT.
  • Stratify cardiac risk across patient panelsStratify cardiovascular risk across larger patient panels.

Feature check

Side-by-side feature check

Feature
Cleerly
Ultromics
FFR CT ModelsPersonalized coronary flow models from CT
-
Plaque AnalyticsQuantifies plaque burden and composition
-
Reporting SupportDrafts report content for cardiology review
-
Care PathwaysRoutes findings into cardiology care pathways
-
Image AnalysisAI analysis of cardiac imaging studies
Risk StratificationStratifies cardiovascular risk from inputs
8 capabilities compared.4 differentiating rows are shown first.

The trade-offs

Pros & cons of each tool

Trade-offs

Cleerly

Pros
  • Plaque characterization plus risk stratification
  • Coronary CT angiography depth and focus
  • Active deployments with major cardiology programs
Cons
  • Best fit requires strong coronary CT volume
  • Workflow integration requires coordinated effort
  • Cardiologist review of every output essential
Trade-offs

Ultromics

Pros
  • Disease-focused AI echocardiography analysis
  • Active heart failure programs
  • Real cardiology echo lab deployments
Cons
  • Adoption depth varies by region and clearance
  • Best suited to established echo lab workflows
  • Cardiologist review remains essential for every output

Final verdict

Best fit depends on your workflow

Catalog verdict · low confidence

Current catalog data shows meaningful overlap between Cleerly and Ultromics. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.

Shared catalog overlap

Cleerly and Ultromics share 9 catalog signals, so the decision should focus on fit rather than broad capability alone.

Differentiators available

Cleerly has 3 visible decision signals and Ultromics has 3.

Score signal

Cleerly has the higher SoftFinders Score in the current catalog data.

TRY THEM YOURSELF

See which one fits your workflow

Both tools have their strengths, the best way to decide is to spend a few minutes inside each.